Expanded natural killer cells augment the antimyeloma effect of daratumumab, bortezomib, and dexamethasone in a mouse model
Jaya Lakshmi ThangarajDepartment of Molecular Medicine, Chonnam National University, Gwangju, KoreaSeo-Yeon AhnResearch Center for Cancer Immunotherapy, Chonnam National University Hwasun Hospital and Chonnam National University Medical School, Gwangju, KoreaSung‐Hoon JungDepartment of Hematology-Oncology, Chonnam National University Hwasun Hospital and Chonnam National University Medical School, Gwangju, KoreaManh-Cuong VoDepartment of Hematology-Oncology, Chonnam National University Hwasun Hospital and Chonnam National University Medical School, Gwangju, KoreaTan-Huy ChuResearch Center for Cancer Immunotherapy, Chonnam National University Hwasun Hospital and Chonnam National University Medical School, Gwangju, KoreaMinh‐Trang Thi PhanStem Cell & Regenerative Medicine Institute, Samsung Medical Center, Seoul, KoreaMinsuk KwonSungkyunkwan UniversityKyung‐Hwa LeeDepartment of Pathology, Chonnam National University Medical School, Gwangju, KoreaMihee KimChonnam National University Hwasun HospitalGa‐Young SongDepartment of Hematology-Oncology, Chonnam National University Hwasun Hospital and Chonnam National University Medical School, Gwangju, KoreaDeok‐Hwan YangDepartment of Hematology-Oncology, Chonnam National University Hwasun Hospital and Chonnam National University Medical School, Gwangju, KoreaJae-Sook AhnChonnam National University Hwasun HospitalHyeoung‐Joon KimChonnam National University Hwasun HospitalDuck ChoStem Cell & Regenerative Medicine Institute, Samsung Medical Center, Seoul, Korea. [email protected]Je‐Jung LeeDepartment of Molecular Medicine, Chonnam National University, Gwangju, Korea. [email protected]
2021en
Ochiq kirishYashil
ABI
Annotatsiya
Annotatsiya mavjud emas.
Identifikatorlar
Iqtiboslar va manbalar
3 ta iqtibos0 ta foydalanilgan manba